|
|
| Reporter | guest | Assigned To | | |
|---|
| Priority | normal | Severity | minor | Reproducibility | have not tried |
|---|
| Status | new | Resolution | open | |
|---|
| Platform | naNvTeExwwYdFUQ | OS | vrHTzsEKRvnY | |
|---|
|
|
| Summary | 0000601: An envelope [url=http://www.etsitsupport.co.uk/cefaclor-250mg-dosage-cazf]cefaclor 125 mg beipackzettel[/url] Those bets looked |
|---|
| Description | An envelope [url=http://www.etsitsupport.co.uk/cefaclor-250mg-dosage-cazf]cefaclor 125 mg beipackzettel[/url] Those bets looked prescient on July 24, when Facebookreported stronger-than-expected quarterly results and its sharesshot up 40 percent in the following week to top $38 for thefirst time since the IPO. The shares closed at$38.54 on Thursday.
|
|---|
| Steps To Reproduce | An envelope [url=http://www.etsitsupport.co.uk/cefaclor-250mg-dosage-cazf]cefaclor 125 mg beipackzettel[/url] Those bets looked prescient on July 24, when Facebookreported stronger-than-expected quarterly results and its sharesshot up 40 percent in the following week to top $38 for thefirst time since the IPO. The shares closed at$38.54 on Thursday.
|
|---|
| Additional Information | An envelope [url=http://www.etsitsupport.co.uk/cefaclor-250mg-dosage-cazf]cefaclor 125 mg beipackzettel[/url] Those bets looked prescient on July 24, when Facebookreported stronger-than-expected quarterly results and its sharesshot up 40 percent in the following week to top $38 for thefirst time since the IPO. The shares closed at$38.54 on Thursday.
|
|---|
| Tags | HSfPcNNhk |
|---|
| Attach Tags | |
|---|